NMR spectra
. 1 H NMR spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S2 . 13 C NMR spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S3 . 1 H, 1 H-COSY spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S4 . 1 H, 1 H-TOCSY spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S5 . HSQC spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S6 . HMBC spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S7 . 1 H NMR spectrum of 2 (600MHz, CDCl3/MeOD, 1:1). Figure S8 . 13 C NMR spectrum of 2 (600MHz, CDCl3/MeOD, 1:1). Figure S9 . 1 H NMR spectrum of intermediate V (400MHz, CDCl3). 2. MS data. Figure S19 . HR-ESI-MS spectrum of bioactive lipid pool isolated from the marine diatom T. weissflogii. Table S1 . Fatty acid composition (methyl derivatives) of 1 by GCMS analysis after methanolysis. Table S2 . Fatty acid composition of main species of the natural pool 1 by LC-ESI -/MS/MS analysis. Figure S20 . Expression of cell surface markers in MoDCs by stimulation with LH-20 bioactive fraction from T. weissflogii. Figure S1 . 1 H NMR spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S2 . 13 C NMR spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S3 . 1 H, 1 H-COSY spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S4 . 1 H, 1 H-TOCSY spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S5 . HSQC spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S6 . HMBC spectrum of 1 (600MHz, CDCl3/MeOD, 1:1). Figure S7 . 1 H NMR spectrum of 2 (600MHz, CDCl3/MeOD, 1:1). Figure S8 . 13 C NMR spectrum of 2 (600MHz, CDCl3/MeOD, 1:1). 
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